127 related articles for article (PubMed ID: 650932)
1. [Fibrinolytic changes in subarachnoid hemorrhage and anti-fibrinolytic therapy--application of an anti-plasmin agent (t-AMCHA)].
Watanabe H; Ishii S; Chigasaki H
Nihon Rinsho; 1978; 36(3):555-62. PubMed ID: 650932
[No Abstract] [Full Text] [Related]
2. Antifibrinolytic therapy in ruptured intracranial aneurysm through repeated monitoring of fibrinolytic activity of blood.
Watanabe H; Ito M; Chigasaki H; Ishii S
Neurol Med Chir (Tokyo); 1976; 16(PT1):91-6. PubMed ID: 66644
[No Abstract] [Full Text] [Related]
3. Antifibrinolytic therapy in subarachnoid hemorrhage.
Jordan KG
N Engl J Med; 1985 Jan; 312(1):52-3. PubMed ID: 3880594
[No Abstract] [Full Text] [Related]
4. Control of Arthus tonsillitis by the administration of an antiplasminic agent.
Kosugi T; Takagi I; Kinjo K; Nakagawa S; Noda Y; Mihara H
Int J Tissue React; 1983; 5(2):205-15. PubMed ID: 6225744
[TBL] [Abstract][Full Text] [Related]
5. Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.
Fodstad H
J Clin Pathol Suppl (R Coll Pathol); 1980; 14():68-73. PubMed ID: 7000850
[No Abstract] [Full Text] [Related]
6. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.
Chandra B
Ann Neurol; 1978 Jun; 3(6):502-4. PubMed ID: 354483
[TBL] [Abstract][Full Text] [Related]
7. The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage.
Schisano G
Surg Neurol; 1978 Oct; 10(4):217-22. PubMed ID: 725719
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid.
Tsementzis SA; Honan WP; Nightingale S; Hitchcock ER; Meyer CH
Acta Neurochir (Wien); 1990; 103(3-4):116-21. PubMed ID: 2205078
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.
Fodstad H; Liliequist B; Schannong M; Thulin CA
Surg Neurol; 1978 Jul; 10(1):9-15. PubMed ID: 356311
[TBL] [Abstract][Full Text] [Related]
10. Proceedings: Preoperative management of patients with aneurysmal subarachnoid haemorrhage. A preliminary comparative study of consecutive and randomized series.
Tovi D
Acta Neurochir (Wien); 1975; 31(3-4):271. PubMed ID: 1181836
[No Abstract] [Full Text] [Related]
11. [Rapid measurement of fibrinolytic activity in CSF by t-AMCA score method. Correlation with concentration of antifibrinolytic agent in CSF (author's transl)].
Nishimatsu T; Shibasaki T; Sasaki H; Nukui H; Kawafuchi J; Okada K
Rinsho Byori; 1980 Mar; 28(3):265-70. PubMed ID: 7373890
[No Abstract] [Full Text] [Related]
12. Fibrinolytic inhibitors for acute gastric haemorrhage.
Br Med J; 1977 Dec; 2(6102):1565-6. PubMed ID: 303927
[No Abstract] [Full Text] [Related]
13. [Possibilities of the use of an inhibitor of hemolysis (AMCHA), by rectal and vaginal administration, for gynecological hemorrhages].
Valsecchi A; Cappelletti M
Minerva Ginecol; 1975 Apr; 27(4):339-47. PubMed ID: 1169724
[No Abstract] [Full Text] [Related]
14. Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).
Fodstad H; Nilsson IM
Acta Neurochir (Wien); 1981; 56(1-2):25-38. PubMed ID: 7195642
[TBL] [Abstract][Full Text] [Related]
15. Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy.
Woo KS; Tse LK; Woo JL; Vallance-Owen J
Br J Clin Pract; 1989 Dec; 43(12):465-6. PubMed ID: 2611113
[No Abstract] [Full Text] [Related]
16. Control of gingival hemorrhage in hemophilic patients by inhibition of fibrinolysis with tranexamic acid.
Sindet-Pedersen S; Stenbjerg S; Ingerslev J
J Periodontal Res; 1988 Jan; 23(1):72-4. PubMed ID: 2963908
[No Abstract] [Full Text] [Related]
17. Preoperative management of patients with aneurysmal subarachnoid hemorrhage.
Tovi D
J Neurosurg Sci; 1975; 19(1-2):59-64. PubMed ID: 1221096
[No Abstract] [Full Text] [Related]
18. Effect of fibrinolysis inhibitor and chemotherapeutics on the growth of human cancers transplanted into nude mice and in tissue culture.
Iwakawa A; Tanaka K
Invasion Metastasis; 1982; 2(4):232-48. PubMed ID: 7188396
[TBL] [Abstract][Full Text] [Related]
19. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.
van Rossum J; Wintzen AR; Endtz LJ; Schoen JH; de Jonge H
Ann Neurol; 1977 Sep; 2(3):238-42. PubMed ID: 365072
[TBL] [Abstract][Full Text] [Related]
20. Letter to the editors of acta neurochirurgica. Management of patients with subarachnoid haemorrhage with tranexamic acid.
Fodstad H; Thulin CA
Acta Neurochir (Wien); 1980; 54(1-2):127-31. PubMed ID: 7435290
[No Abstract] [Full Text] [Related]
[Next] [New Search]
